Cargando…
Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer
Prostate cancer is the third most common cause of male cancer death in developed countries, and one of the most comprehensively characterized human cancers. Roughly 60% of prostate cancers harbor gene fusions that juxtapose ETS-family transcription factors with androgen regulated promoters. A second...
Autores principales: | Annala, Matti, Kivinummi, Kati, Tuominen, Joonas, Karakurt, Serdar, Granberg, Kirsi, Latonen, Leena, Ylipää, Antti, Sjöblom, Liisa, Ruusuvuori, Pekka, Saramäki, Outi, Kaukoniemi, Kirsi M., Yli-Harja, Olli, Vessella, Robert L., Tammela, Teuvo L.J, Zhang, Wei, Visakorpi, Tapio, Nykter, Matti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467434/ https://www.ncbi.nlm.nih.gov/pubmed/25749039 |
Ejemplares similares
-
Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
por: Kaukoniemi, Kirsi M, et al.
Publicado: (2015) -
Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
por: Granberg, Kirsi J, et al.
Publicado: (2017) -
DOT1L-HES6 fusion drives androgen independent growth in prostate cancer
por: Annala, Matti, et al.
Publicado: (2014) -
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
por: Latonen, Leena, et al.
Publicado: (2018) -
Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
por: Lehtinen, Birgitta, et al.
Publicado: (2017)